Monthly Archives: April 2013

Marks & Clerk Releases Life Sciences 2013 Report

On Monday, the international law firm Marks & Clerk released it’s 2013 Life Sciences Report at the BIO International Convention in Chicago. This 50-plus page report is wide-ranging, containing both the views of life science leaders on marketplace issues like … Continue reading

Posted in Miscellaneous | Tagged , , , , , , , | Leave a comment

Myriad Argued Before The Supreme Court – Some Snippets

I confess that I’ve become addicted to this case and just finished all 63 pages of the transcript of the oral argument that took place on Monday. I won’t try to summarize it, but rather will try to review some … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , | Leave a comment

Saffran v. J&J – When Defining Equals Disclaiming

A guest post from Theresa Stadheim of Schwegman Lundberg & Woessner, P.A. In Bruce N. Saffran, M.D., Ph.D., v. Johnson & Johnson and Cordis Corporation, Appeal No. 2012-1043 (Fed. Cir. April 4, 2013, decision by Lourie), the Federal Circuit reversed … Continue reading

Posted in Claim Interpretation | Tagged , , , , , , , | Leave a comment

Approaches to Claiming Diagnostic Methods using Biomarkers in the EPO

Find linked below a guest post from Dr. Stefan Danner in regards to drafting diagnostic claims in Europe. Diagnostic Claims    

Posted in Patent Eligible Subject Matter | Tagged , , , , , , | Leave a comment